View Cart (0 items)

Pharmaceutical

Pfizer to pay $14 million to settle allegations of illegal off-label marketing

October 25, 2011
Normal0falsefalsefalseEN-USX-NONEX-NONEMicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New
Read More

‘World’s first malaria vaccine’ proven effective in clinical trial

October 20, 2011
Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt;
Read More

Bristol-Myers Squibb Foundation awards $2.12 million in grants to help soldiers heal from emotional wounds

October 19, 2011
Normal0falsefalsefalseEN-USX-NONEX-NONEMicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New
Read More

Roche to Buy US-based Anadys for $230 Million

October 17, 2011
The Associated Press reports, Swiss drugmaker Roche Holding AG announced it is paying $230 million to take over Anadys Pharmaceuticals Inc., a U.S.-based specialist in the development of hepatitis C
Read More

International Stem Cell Corp. completes first series of trials on neuronal cells

October 12, 2011
CARLSBAD, Calif. — International Stem Cell Corporation announced Tuesday the successful completion of the first series of preclinical studies designed to support the safety and utility of neuronal cells derived
Read More

Bristol-Myers Squibb Foundation partners with WHO to control spread of tuberculosis

October 11, 2011
PRINCETON, N.J. — The Bristol-Myers Squibb Foundation today announced a collaboration with the World Health Organization''s (WHO) Stop TB Department for a two-year pilot initiative to strengthen community based
Read More

New Product Line for Advanced Colony Counting in Quality Assurance Labs of the Pharmaceutical Industry

October 7, 2011
Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan;
Read More

Pfizer to open pharmaceutical plant in Saudi Arabia

October 5, 2011
RABIGH, Saudi Arabia -- Pfizer Inc. has signed an agreement to open a pharmaceutical manufacturing plant in Saudi Arabia, Bloomberg reported. The plant will begin production in 2015 and
Read More

Lycera Corp. names Kathleen M. Metters as president, CEO

October 4, 2011
ANN ARBOR, Mich. – Biopharmaceutical company Lycera Corp. announced that Kathleen M. Metters, former senior vice president and head of worldwide basic research at Merck, has been named president
Read More

Merck to pay $1.5 million civil penalty for environmental violations

September 29, 2011
PHILADELPHIA — Pharmaceutical company Merck has agreed to pay a $1.5 million civil penalty to settle violations of federal environmental laws at its manufacturing facilities in Riverside and West Point,
Read More